Literature DB >> 22431623

Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197.

Enrico Malito1, Badry Bursulaya, Connie Chen, Paola Lo Surdo, Monica Picchianti, Enrico Balducci, Marco Biancucci, Ansgar Brock, Francesco Berti, Matthew James Bottomley, Mikkel Nissum, Paolo Costantino, Rino Rappuoli, Glen Spraggon.   

Abstract

CRM197 is an enzymatically inactive and nontoxic form of diphtheria toxin that contains a single amino acid substitution (G52E). Being naturally nontoxic, CRM197 is an ideal carrier protein for conjugate vaccines against encapsulated bacteria and is currently used to vaccinate children globally against Haemophilus influenzae, pneumococcus, and meningococcus. To understand the molecular basis for lack of toxicity in CRM197, we determined the crystal structures of the full-length nucleotide-free CRM197 and of CRM197 in complex with the NAD hydrolysis product nicotinamide (NCA), both at 2.0-Å resolution. The structures show for the first time that the overall fold of CRM197 and DT are nearly identical and that the striking functional difference between the two proteins can be explained by a flexible active-site loop that covers the NAD binding pocket. We present the molecular basis for the increased flexibility of the active-site loop in CRM197 as unveiled by molecular dynamics simulations. These structural insights, combined with surface plasmon resonance, NAD hydrolysis, and differential scanning fluorimetry data, contribute to a comprehensive characterization of the vaccine carrier protein, CRM197.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22431623      PMCID: PMC3325714          DOI: 10.1073/pnas.1201964109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  The crystal structure of diphtheria toxin.

Authors:  S Choe; M J Bennett; G Fujii; P M Curmi; K A Kantardjieff; R J Collier; D Eisenberg
Journal:  Nature       Date:  1992-05-21       Impact factor: 49.962

2.  Diphtheria toxin mutant CRM197 is an inhibitor of protein synthesis that induces cellular toxicity.

Authors:  Jian Qiao; Karim Ghani; Manuel Caruso
Journal:  Toxicon       Date:  2007-10-01       Impact factor: 3.033

3.  Dimeric form of diphtheria toxin: purification and characterization.

Authors:  S F Carroll; J T Barbieri; R J Collier
Journal:  Biochemistry       Date:  1986-05-06       Impact factor: 3.162

4.  Structure of the isolated catalytic domain of diphtheria toxin.

Authors:  M S Weiss; S R Blanke; R J Collier; D Eisenberg
Journal:  Biochemistry       Date:  1995-01-24       Impact factor: 3.162

5.  The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197.

Authors:  G Giannini; R Rappuoli; G Ratti
Journal:  Nucleic Acids Res       Date:  1984-05-25       Impact factor: 16.971

Review 6.  How bacterial carbohydrates influence the adaptive immune system.

Authors:  Fikri Y Avci; Dennis L Kasper
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

7.  Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.

Authors:  Andrew J Pollard; Kirsten P Perrett; Peter C Beverley
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

8.  Crystal structure of the complex of diphtheria toxin with an extracellular fragment of its receptor.

Authors:  G V Louie; W Yang; M E Bowman; S Choe
Journal:  Mol Cell       Date:  1997-12       Impact factor: 17.970

9.  Hydrolysis of nicotinamide adenine dinucleotide by choleragen and its A protomer: possible role in the activation of adenylate cyclase.

Authors:  J Moss; V C Manganiello; M Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  36 in total

1.  Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers.

Authors:  Rashmi Jalah; Oscar B Torres; Alexander V Mayorov; Fuying Li; Joshua F G Antoline; Arthur E Jacobson; Kenner C Rice; Jeffrey R Deschamps; Zoltan Beck; Carl R Alving; Gary R Matyas
Journal:  Bioconjug Chem       Date:  2015-06-05       Impact factor: 4.774

2.  Investigating the immunodominance of carbohydrate antigens in a bivalent unimolecular glycoconjugate vaccine against serogroup A and C meningococcal disease.

Authors:  Roberto Adamo; Alberto Nilo; Carole Harfouche; Barbara Brogioni; Simone Pecetta; Giulia Brogioni; Evita Balducci; Vittoria Pinto; Sara Filippini; Elena Mori; Marta Tontini; Maria Rosaria Romano; Paolo Costantino; Francesco Berti
Journal:  Glycoconj J       Date:  2014-09-26       Impact factor: 2.916

3.  High Throughput Differential Scanning Fluorimetry (DSF) Formulation Screening with Complementary Dyes to Assess Protein Unfolding and Aggregation in Presence of Surfactants.

Authors:  Sean M McClure; Patrick L Ahl; Jeffrey T Blue
Journal:  Pharm Res       Date:  2018-03-05       Impact factor: 4.200

4.  Design and development of stable, water-soluble, human Toll-like receptor 2 specific monoacyl lipopeptides as candidate vaccine adjuvants.

Authors:  Deepak B Salunke; Seth W Connelly; Nikunj M Shukla; Alec R Hermanson; Lauren M Fox; Sunil A David
Journal:  J Med Chem       Date:  2013-07-10       Impact factor: 7.446

5.  Molecular Cloning, Structural Modeling and the Production of Soluble Triple-Mutated Diphtheria Toxoid (K51E/G52E/E148K) Co-expressed with Molecular Chaperones in Recombinant Escherichia coli.

Authors:  Naphatsamon Uthailak; Pornpimol Mahamad; Pamorn Chittavanich; Somchai Yanarojana; Wassana Wijagkanalan; Jean Petre; Watanalai Panbangred
Journal:  Mol Biotechnol       Date:  2017-05       Impact factor: 2.695

6.  Needle-Free Dermal Delivery of a Diphtheria Toxin CRM197 Mutant on Potassium-Doped Hydroxyapatite Microparticles.

Authors:  Nikolas T Weissmueller; Heiko A Schiffter; Robert C Carlisle; Christine S Rollier; Andrew J Pollard
Journal:  Clin Vaccine Immunol       Date:  2015-03-25

7.  Chemical synthesis of the outer core oligosaccharide of Escherichia coli R3 and immunological evaluation.

Authors:  Wenjing Shang; Zhongying Xiao; Zaikuan Yu; Na Wei; Guohui Zhao; Qing Zhang; Mohui Wei; Xuan Wang; Peng George Wang; Tiehai Li
Journal:  Org Biomol Chem       Date:  2015-03-12       Impact factor: 3.876

Review 8.  Heparin-binding Peptides as Novel Therapies to Stop SARS-CoV-2 Cellular Entry and Infection.

Authors:  Omid Tavassoly; Farinaz Safavi; Iman Tavassoly
Journal:  Mol Pharmacol       Date:  2020-09-10       Impact factor: 4.436

9.  Clinical significance of serum ADP-ribosylation and NAD glycohydrolase activity in patients with colorectal cancer.

Authors:  Başak Varol; Özlem Coşkun; Senem Karabulut; Kürşat Rahmi Serin; Oktar Asoğlu; Işıl Albeniz; Faruk Taş; Rüstem Nurten
Journal:  Tumour Biol       Date:  2014-02-18

10.  Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice.

Authors:  Eva Conde; Romain Bertrand; Bianca Balbino; Jonathan Bonnefoy; Julien Stackowicz; Noémie Caillot; Fabien Colaone; Samir Hamdi; Raïssa Houmadi; Alexia Loste; Jasper B J Kamphuis; François Huetz; Laurent Guilleminault; Nicolas Gaudenzio; Aurélie Mougel; David Hardy; John N Snouwaert; Beverly H Koller; Vincent Serra; Pierre Bruhns; Géraldine Grouard-Vogel; Laurent L Reber
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.